Systematic Financial Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-62,080
Closed -$1.53M 666
2017
Q1
$1.53M Sell
62,080
-5,650
-8% -$133K 0.03% 519
2016
Q4
$1.72M Sell
67,730
-2,595
-4% -$57.6K 0.03% 466
2016
Q3
$1.4M Sell
70,325
-7,700
-10% -$135K 0.02% 519
2016
Q2
$1.11M Sell
78,025
-1,760
-2% -$26.9K 0.02% 536
2016
Q1
$1.24M Buy
79,785
+235
+0.3% +$3.37K 0.02% 507
2015
Q4
$1.37M Sell
79,550
-43,765
-35% -$633K 0.02% 525
2015
Q3
$1.5M Buy
+123,315
New +$1.58M 0.02% 567

Other funds holding LMAT

Systematic Financial Management's LMAT Position: Q2 2017 in Review

Systematic Financial Management sold out of LeMaitre Vascular (LMAT) in Q2 2017, closing a stake of 62,080 shares — an estimated $1.53M sold.

Systematic Financial Management first reported a position in LMAT in Q3 2015 and held it in 7 quarters. The position peaked at $1.72M in Q4 2016. 143 funds tracked by Wall St. Rank hold LMAT as of Q2 2017.

  • Systematic Financial Management reported no remaining LeMaitre Vascular position as of Q2 2017 after selling out during the quarter.
  • Systematic Financial Management sold 62,080 LeMaitre Vascular shares in Q2 2017, an estimated $1.53M.
  • Systematic Financial Management first reported a position in LeMaitre Vascular in Q3 2015 and held it in 7 quarters.
  • Systematic Financial Management's LeMaitre Vascular position peaked at $1.72M in Q4 2016.
  • 143 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2017.

Based on Systematic Financial Management's 13F filing for Q2 2017, filed 10 Aug 2017.